InsiderTrades

Form 4 for PFE Pfizer

Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-28 · accession 0001225208-22-003725 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-01 2022-02-28 PFE SAHNI PAYAL EVP F - Tax $46.94 -1,049 18.8K -5% -$49.2K
D 2022-03-01 2022-02-28 PFE SAHNI PAYAL EVP A - Grant $0.00 +4,295 4,295 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-28 F D 1,049 $46.94 18,753 D — — (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
2 Derivative Phantom Stock Units 2022-02-28 A A 4,295 $0.00 4,295 D — · — to — 4,295 Common Stock (F3) The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan. (F2) Each unit represents one phantom share of common stock. (F4) The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.